Cook Meredith sold 500 ANI Pharmaceuticals shares at $70.79 each on 2026-09-14, leaving 73,924 shares after the transaction. The sale represented about 0.7% of Meredith’s prior holding, giving investors a precise measure of the transaction’s size relative to the executive’s position.

Key Highlights

  • Cook Meredith held 73,924 ANI Pharmaceuticals shares after the transaction.
  • The transaction carried code S, denoting an open-market sale.
  • The disposal represented about 0.7% of Cook Meredith’s prior holding.

ANI PHARMACEUTICALS INC (NASDAQ: ANIP) executive Cook Meredith sold 500 shares in the company. The transaction took place on 14 September 2026 at $70.79 per share.

Executive Sale Details

Cook Meredith is identified as ANI Pharmaceuticals’ SR. VP, GENERAL COUNSEL & SEC. Meredith held 73,924 shares after the transaction. The sale represented about 0.7% of Meredith’s prior share holding. The disclosed percentage measures the sale against Meredith’s previous holding.